Dispensing, Storage and Accountability Sample Clauses

Dispensing, Storage and Accountability. The study drugs will be supplied by Tonix or a designee to be used exclusively in the clinical study according to the instructions in this protocol. The investigator is responsible for dispensing the study drugs according to the dosage scheme and for ensuring proper storage of the products. Until study drug is dispensed to the patients, it must be stored in a securely locked refrigerated area that is not generally accessible. The key to the storage area is to be kept by the investigator or designee responsible for the study drug. The storage will be accessible only to those persons authorized by the investigator to dispense the products. The investigator or designee must confirm the receipt of the IP with his or her signature. A copy of this receipt must be kept by the investigator and another copy will be stored at Tonix or its designee. The investigator or investigator designee must maintain adequate records showing the receipt, dispensing, return, or other disposition of study drugs, including the date, quantity, batch or code number, and identification of patients who received each bottle of study drug. The investigator will not supply study drugs to any person except those named as sub- investigators on the FDA form 1572, designated study personnel, and patients in this study. The investigator will not dispense the study drugs from any study sites other than those listed on the FDA form 1572. Study drugs may not be relabeled or reassigned for use to other patients. If any of the study drug is not dispensed, or is lost, stolen, spilled, unusable, or received in a damaged container, this information must be documented and reported to the sponsor and appropriate regulatory agencies, as required. Upon completion of the study, all study drug (partly used, unused, and empty packaging, e.g., vials with intranasal applicators) must be left in the original packaging and shipped back to drug depot.
View Source

Related to Dispensing, Storage and Accountability

  • Service Accountability Agreements The HSP acknowledges that if the LHIN and the HSP enter into negotiations for a subsequent service accountability agreement, subsequent funding may be interrupted if the next service accountability agreement is not executed on or before the expiration date of this Agreement.

  • Accountability Actuaries and external auditors will be appointed by the Trust. Audited financial statements, and an actuarial evaluation report will be obtained for the Trust on an annual basis. The actuarial report will include projections for the Trust for a period of not less than 3 years into the future.

  • A Service Accountability Agreement This Agreement is a service accountability agreement for the purposes of the Enabling Legislation.

  • Health Care Accountability Ordinance If Administrative Code Chapter 12Q applies to this contract, Contractor shall comply with the requirements of Chapter 12Q. For each Covered Employee, Contractor shall provide the appropriate health benefit set forth in Section 12Q.3 of the HCAO. If Contractor chooses to offer the health plan option, such health plan shall meet the minimum standards set forth by the San Francisco Health Commission. Information about and the text of the Chapter 12Q, as well as the Health Commission’s minimum standards, is available on the web at ▇▇▇▇://▇▇▇▇▇.▇▇▇/olse/hcao. Contractor is subject to the enforcement and penalty provisions in Chapter 12Q. Any Subcontract entered into by Contractor shall require any Subcontractor with 20 or more employees to comply with the requirements of the HCAO and shall contain contractual obligations substantially the same as those set forth in this Section.

  • Wall Street Transparency and Accountability Act In connection with Section 739 of the Wall Street Transparency and Accountability Act of 2010 (“WSTAA”), the parties hereby agree that neither the enactment of WSTAA or any regulation under the WSTAA, nor any requirement under WSTAA or an amendment made by WSTAA, shall limit or otherwise impair either party’s otherwise applicable rights to terminate, renegotiate, modify, amend or supplement this Confirmation or the Agreement, as applicable, arising from a termination event, force majeure, illegality, increased costs, regulatory change or similar event under this Confirmation, the Equity Definitions incorporated herein, or the Agreement (including, but not limited to, rights arising from Change in Law, Hedging Disruption, Increased Cost of Hedging, an Excess Ownership Position, or Illegality (as defined in the Agreement)).